Dual-Receptor–Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates-Reference-Cited by-同舟云学术

Dual-Receptor–Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates

Published:2015-10-01 Issue:3 Volume:57 Page:444-452
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Razumienko Eva J.,Chen Jason C.,Cai Zhongli,Chan Conrad,Reilly Raymond M.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference34 articles.

1. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

2. Targeted Therapy in her2-Positive Metastatic Breast Cancer: A Review of the Literature

3. Resistance to human epidermal growth factor receptor type 2-targeted therapies

4. Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

5. Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bispecific radioimmunoconjugates exploit receptor heterogeneity for positron emission tomography of tumors expressing HER2 and/or EGFR;iScience;2024-05

2. The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years;Current Medical Imaging Formerly Current Medical Imaging Reviews;2023-07

3. Current status of contemporary diagnostic radiotracers in the management of breast cancer: first steps toward theranostic applications;EJNMMI Research;2023-05-17

4. Engineering of a Bispecific Nanofitin with Immune Checkpoint Inhibitory Activity Conditioned by the Cross-Arm Binding to EGFR and PDL1;Biomolecules;2023-03-31

5. Molecular imaging of HER2 receptor: Targeting HER2 for imaging and therapy in nuclear medicine;Frontiers in Molecular Biosciences;2023-03-02